| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S40273-014-0174-6 |
| P698 | PubMed publication ID | 24859304 |
| P50 | author | Tore K. Kvien | Q65660760 |
| Rikke Helene Moe | Q89133233 | ||
| Till Uhlig | Q39272238 | ||
| P2860 | cites work | Non-pharmacological interventions for fatigue in rheumatoid arthritis | Q24200269 |
| Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis | Q24240321 | ||
| 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis | Q26828418 | ||
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 | ||
| Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. | Q53293619 | ||
| Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project. | Q54417889 | ||
| American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials | Q57169361 | ||
| Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors | Q57751173 | ||
| Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? | Q58160942 | ||
| Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis | Q59394199 | ||
| The prevalence of rheumatoid arthritis in Sweden | Q60777163 | ||
| The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability | Q64111451 | ||
| High incidence and prevalence of rheumatoid arthritis in Pima Indians | Q69739463 | ||
| The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study | Q73342276 | ||
| Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register | Q73574433 | ||
| The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century | Q74405874 | ||
| Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France | Q79373047 | ||
| Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway, 1994-2004 | Q80062013 | ||
| Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania | Q81093885 | ||
| Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study | Q82190500 | ||
| Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis | Q84172541 | ||
| Productivity loss at work; health-related and work-related factors | Q84920357 | ||
| Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort | Q85085364 | ||
| Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic | Q85777778 | ||
| The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis | Q27022403 | ||
| Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. | Q27692555 | ||
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A mindfulness-based group intervention to reduce psychological distress and fatigue in patients with inflammatory rheumatic joint diseases: a randomised controlled trial | Q30557317 | ||
| Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines | Q30926725 | ||
| Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. | Q33307666 | ||
| A systematic review of the effects of dynamic exercise in rheumatoid arthritis | Q33496161 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study | Q33537396 | ||
| Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study | Q33540305 | ||
| Cost-of-illness studies. Useful for health policy? | Q33584102 | ||
| The prevalence of rheumatic diseases in central Greece: a population survey | Q33588016 | ||
| Why do people with rheumatoid arthritis still die prematurely? | Q33697879 | ||
| Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. | Q33808270 | ||
| The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis | Q34027412 | ||
| Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. | Q34089998 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry | Q34249182 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Are persons with rheumatoid arthritis deconditioned? A review of physical activity and aerobic capacity. | Q34451231 | ||
| Treating rheumatoid arthritis to target: recommendations of an international task force | Q34462557 | ||
| Lack of exercise is a major cause of chronic diseases | Q34560916 | ||
| Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review | Q34574374 | ||
| The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. | Q34808086 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. | Q34986307 | ||
| Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis | Q35084199 | ||
| Prevalence of rheumatoid arthritis in Italy: the Chiavari Study | Q35547869 | ||
| The burden of musculoskeletal diseases in the general population of Spain: results from a national survey | Q35549907 | ||
| Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania | Q35552444 | ||
| Predictive factors of work disability in rheumatoid arthritis: a systematic literature review | Q35553588 | ||
| Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project | Q43493651 | ||
| Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? | Q43808737 | ||
| Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study | Q43898004 | ||
| Inequities in access to biologic and synthetic DMARDs across 46 European countries | Q44191676 | ||
| Low and stable prevalence of rheumatoid arthritis in northern France | Q44811300 | ||
| Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics | Q45196076 | ||
| Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study | Q45308109 | ||
| Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study | Q45359876 | ||
| Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study | Q45730150 | ||
| Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth? | Q45766371 | ||
| Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010. | Q45790066 | ||
| Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial | Q45842857 | ||
| The burden of rheumatoid arthritis and access to treatment: health burden and costs | Q46256192 | ||
| The burden of rheumatoid arthritis and access to treatment: uptake of new therapies | Q46506569 | ||
| Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register | Q48151392 | ||
| A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance | Q48378293 | ||
| Comparative quality of life in patients with depression and rheumatoid arthritis | Q48907082 | ||
| The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. | Q50631890 | ||
| Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. | Q50661137 | ||
| Abdominal discomfort in patients with rheumatoid arthritis is associated with physical and mental function, self-reported disease activity, and use of anti-inflammatory medication. | Q50714333 | ||
| Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003. | Q50794887 | ||
| The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. | Q50913470 | ||
| Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice. | Q51162994 | ||
| Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. | Q51752631 | ||
| Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. | Q51892872 | ||
| Is rheumatoid arthritis disappearing? | Q35554758 | ||
| Prevalence of rheumatoid arthritis in France: 2001 | Q35554799 | ||
| Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. | Q35557984 | ||
| Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. | Q35605617 | ||
| Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US. | Q35638583 | ||
| The Oslo experience with arthritis registries. | Q35669636 | ||
| Epidemiology and burden of illness of rheumatoid arthritis | Q35780338 | ||
| Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys | Q35799592 | ||
| Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present | Q36713901 | ||
| The association of depression and anxiety with medical symptom burden in patients with chronic medical illness | Q36750861 | ||
| A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study | Q37206622 | ||
| A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study | Q37206628 | ||
| Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database | Q37374953 | ||
| Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). | Q37465556 | ||
| Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study | Q37542785 | ||
| Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project | Q37715952 | ||
| Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis: meta-analysis of randomized controlled trials | Q37768732 | ||
| Nonpharmacological treatment of rheumatoid arthritis | Q37846491 | ||
| The burden of illness of rheumatoid arthritis | Q37848120 | ||
| What is the clinical relevance of erosions and joint space narrowing in RA? | Q37976245 | ||
| Malignancy as a comorbidity in rheumatic diseases | Q38029322 | ||
| Inflammatory arthritis as a novel risk factor for cardiovascular disease | Q38030254 | ||
| Lifestyle- and behaviour-change interventions in musculoskeletal conditions. | Q38032368 | ||
| Physical activity in rheumatoid arthritis: a systematic review | Q38042819 | ||
| The role of biosimilars in the treatment of rheumatic diseases | Q38068691 | ||
| Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. | Q38076912 | ||
| Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis. | Q38129036 | ||
| Facilitators to implement standards of care for rheumatoid arthritis and osteoarthritis: the EUMUSC.NET project | Q38196985 | ||
| Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. | Q38466026 | ||
| Prevalence of rheumatoid arthritis in Dublin, Ireland: a population based survey | Q39521270 | ||
| Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants | Q39729048 | ||
| Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden | Q39962493 | ||
| Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register | Q40360229 | ||
| Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients | Q40416007 | ||
| Which patients with rheumatoid arthritis are still working? | Q42748085 | ||
| P433 | issue | 9 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 841-851 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | PharmacoEconomics | Q7180778 |
| P1476 | title | The burden of disease in rheumatoid arthritis | |
| P478 | volume | 32 |
| Q90080052 | "Not Thinking that This Means the End When You Are Seriously Ill but Doing Something Positive about It"-A Qualitative Study of Living with a Life-Changing Disease |
| Q64119713 | 'Preclinical' rheumatoid arthritis in patients with celiac disease: A cross-sectional study |
| Q64060952 | An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model |
| Q46400812 | Anti-Inflammatory and Antioxidant Actions of Copaiba Oil Are Related to Liver Cell Modifications in Arthritic Rats |
| Q57570267 | Anti-Inflammatory and Antioxidant Actions of Methyl Jasmonate Are Associated with Metabolic Modifications in the Liver of Arthritic Rats |
| Q35901757 | Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis |
| Q88990740 | Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis |
| Q91663787 | Dose-response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case-control study |
| Q91576544 | Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial |
| Q36761476 | Estimating the Economic Burden of Rheumatoid Arthritis in Taiwan Using the National Health Insurance Database |
| Q94517901 | Hospitalization burden and comorbidities of patients with rheumatoid arthritis in Spain during the period 2002-2017 |
| Q92237919 | Identification of Characteristic Autoantibodies Associated With Deficiency Pattern in Traditional Chinese Medicine of Rheumatoid Arthritis Using Protein Chips |
| Q46957950 | Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry |
| Q46114963 | Managing Rheumatoid Arthritis with Dietary Interventions |
| Q90750042 | Methyl Jasmonate Reduces Inflammation and Oxidative Stress in the Brain of Arthritic Rats |
| Q47108715 | Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland |
| Q37662723 | Non-medical costs during the first year after diagnosis in two cohorts of patients with early rheumatoid arthritis, enrolled 10 years apart |
| Q37639498 | One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis: Results of a Randomized Controlled Trial |
| Q36464143 | Oxidative changes in the blood and serum albumin differentiate rats with monoarthritis and polyarthritis |
| Q58572457 | Pharmacologic Effect of Miao Medicine Maxim. on Collagen-Induced Arthritis in Rats |
| Q33783557 | Quality of life in patients with established rheumatoid arthritis: A phenomenographic study |
| Q60954470 | Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study |
| Q47807650 | Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons |
| Q48219239 | Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study. |
| Q33602177 | Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity |
| Q38390760 | Serum Levels of Copper and Zinc in Patients with Rheumatoid Arthritis: a Meta-analysis. |
| Q48188706 | Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015. |
| Q39976803 | The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic Agents |
| Q55392751 | The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases. |
| Q47133987 | The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial |
| Q36895220 | The influence of lifestyle habits on quality of life in patients with established rheumatoid arthritis-A constant balancing between ideality and reality |
| Q96231883 | The role of advanced MRI in the development of treat-to-target therapeutic strategies, patient stratification and phenotyping in rheumatoid arthritis |
| Q33714344 | The role of circulating miR-146a in patients with rheumatoid arthritis treated by Tripterygium wilfordii Hook F |
| Q64247906 | Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies |
Search more.